Background Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications in patients with stable angina and non-ST-segment elevation acute coronary syndrome...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!